IN8bio, Inc. (“IN8bio”) is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancers by employing allogeneic, autologous and genetically modified gamma-delta T cells. 

Biotechnology

Health Care

Therapeutics

IN8Bio

IN8Bio's headquarters in Birmingham, AL, United States

William Ho

Lawrence Lamb, PhD

Kate Rochlin

Patrick McCall

Lawrence Lamb

Pat McCall

Michael Bishop

Peter Brandt

Dieter Kabelitz

Siraj Ali

Marcela Maus

Bruce Levine

Emily Fairbairn

Alan S. Roemer

Bianca Santomasso

Jeremy R. Graff

The Leadership Team at IN8Bio is responsible for setting the strategic direction and vision of the company, guiding the development and commercialization of innovative cancer therapies. This team, composed of experts in operations, science, finance, and medicine, collaborates to drive research initiatives, oversee clinical trials, and ensure effective resource allocation to advance the company's mission in the biopharmaceutical industry. Their combined expertise fosters innovation and enhances IN8Bio's position in the competitive landscape of cancer treatment.

Leadership Team

The Medical and Technical Roles team at IN8Bio is responsible for the development and manufacturing of advanced cell therapies. This team ensures the quality and efficacy of gamma-delta T cell therapies through rigorous testing, processing, and technical support, playing a crucial role in advancing innovative cancer treatments from the laboratory to clinical application.

Medical and Technical Roles

��

IN8Bio

Org chart

Board & advisors

Teams

Leadership Team

Medical and Technical Roles

Offices

��������

IN8Bio

Org chart

Board & advisors

Teams

Leadership Team

Medical and Technical Roles

Offices

Related companies

��